Research ArticleArticle
Comparison of the Circulating Metabolite Profile of PF-04991532, a Hepatoselective Glucokinase Activator, Across Preclinical Species and Humans: Potential Implications in Metabolites in Safety Testing Assessment
Raman Sharma, John Litchfield, Arthur Bergman, Karen Atkinson, David Kazierad, Stephanie M. Gustavson, Li Di, Jeffrey A. Pfefferkorn and Amit S. Kalgutkar
Drug Metabolism and Disposition February 2015, 43 (2) 190-198; DOI: https://doi.org/10.1124/dmd.114.061218
Raman Sharma
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
John Litchfield
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
Arthur Bergman
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
Karen Atkinson
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
David Kazierad
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
Stephanie M. Gustavson
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
Li Di
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
Jeffrey A. Pfefferkorn
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)
Amit S. Kalgutkar
Pfizer Inc., Groton, Connecticut (R.S., A.B., K.A., S.M.G., L.D.); and Pfizer Inc., Cambridge, Massachusetts (J.L., D.K., J.A.P., A.S.K.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Circulating Metabolites of PF-04991532
Raman Sharma, John Litchfield, Arthur Bergman, Karen Atkinson, David Kazierad, Stephanie M. Gustavson, Li Di, Jeffrey A. Pfefferkorn and Amit S. Kalgutkar
Drug Metabolism and Disposition February 1, 2015, 43 (2) 190-198; DOI: https://doi.org/10.1124/dmd.114.061218
Research ArticleArticle
Circulating Metabolites of PF-04991532
Raman Sharma, John Litchfield, Arthur Bergman, Karen Atkinson, David Kazierad, Stephanie M. Gustavson, Li Di, Jeffrey A. Pfefferkorn and Amit S. Kalgutkar
Drug Metabolism and Disposition February 1, 2015, 43 (2) 190-198; DOI: https://doi.org/10.1124/dmd.114.061218
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement